Home › Ovarian Cancer › Florida › Miami Beach
Ovarian Cancer clinical trials in Miami Beach, FL
10 studies for Ovarian Cancer are looking for participants at sites in and around Miami Beach (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
RecruitingPhase 2
- Mount Sinai Medical Center /ID# 274868, Miami Beach
A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
RecruitingPhase 2
- Site 0173 - Mount Sinai Medical Center, Miami Beach
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
RecruitingPhase 3
- Mount Sinai Braman Comprehensive Cancer Center, Miami Beach
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
RecruitingPhase 3
- Mount Sinai Cancer Center ( Site 0029), Miami Beach
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
RecruitingPhase 2
- Mount Sinai Comprehensive Cancer Center, Miami Beach
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
RecruitingPhase 3
- Mount Sinai Braman Comprehensive Cancer Center ( Site 0078), Miami Beach
A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
RecruitingPhase 2/3
- Mount Sinai Comprehensive Cancer Center, Miami Beach
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
RecruitingPhase 2
- 335, Miami Beach
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
RecruitingPhase 3
- Mount Sinai Medical Center, Miami Beach
A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors
RecruitingPhase 1
- Mount Sinai Medical Center, Miami Beach
About Ovarian Cancer
Ovarian cancer is a cancerous tumor that forms in the tissues of an ovary. The ovaries are a pair of female reproductive glands that make eggs and female hormones.
More about Ovarian Cancer on MedlinePlus
Ovarian Cancer trials in other cities
- Houston, TX89 studies
- New York City, NY69 studies
- Boston, MA61 studies
- Los Angeles, CA50 studies
- Nashville, TN49 studies
- Arlington, VA46 studies
- Philadelphia, PA44 studies
- Columbus, OH39 studies
- St. Louis, MO38 studies
- Chicago, IL36 studies
- San Antonio, TX31 studies
- Cleveland, OH30 studies
Other studies in Miami Beach
- Endometrial Cancer8 studies
- Colorectal Cancer6 studies
- Breast Cancer6 studies
- Prostate Cancer6 studies
- Non-Small Cell Lung Cancer4 studies
- Cancer (all types)4 studies
- Chronic Lymphocytic Leukemia4 studies
- Heart Failure3 studies
- Lung Cancer3 studies
- Uterine Cancer3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.